Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Conditioned medium from mesenchymal stem cells: Towards skin tissue engineering and wound healing

Nasiri N., Hemmati P., Tabaie SM.

Narrative Review on Diabetic Foot, Chronic Wound, Burns, Scar, published in Iran J Basic Med Sci (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Iran J Basic Med Sci (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42004518
PMCID
PMC13090949
DOI
10.22038/ijbms.2025.88552.19121

Abstract (original English)

Mesenchymal stem cells (MSCs) have emerged as a promising tool in regenerative medicine, particularly in skin tissue engineering and wound healing. Their paracrine activity, mediated by the secretion of bioactive molecules into conditioned medium (CM), has attracted significant attention as a cell-free therapeutic alternative. This review comprehensively examines the role of MSC-derived CM in promoting skin regeneration and wound repair. We discuss the key components of CM - growth factors, cytokines, extracellular vesicles, and miRNAs - that collectively modulate inflammation, angiogenesis, fibroblast proliferation, and extracellular matrix remodeling. Furthermore, we highlight the mechanisms by which CM enhances epithelialization, collagen synthesis, and scar reduction. Preclinical and clinical studies demonstrating the efficacy of MSC-CM in treating acute and chronic wounds, such as diabetic ulcers and burns, are critically evaluated. Challenges related to standardization, scalability, and regulatory approval are also addressed. This review underscores the potential of MSC-CM as a transformative approach in skin tissue engineering and wound healing, while calling for further research to optimize its therapeutic application.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research